Is Ranibizumab Superior to Laser for DME?
November 15, 2009
The end of laser for diabetic macular edema? I think so. A six month trial published in Ophthalmology comparing ranibizumab to laser showed clear superiority (not even close) to focal/grid for diabetic macular edema. I honestly think I will start to offer this to my patients as first line treatment- I hate the laser’s destructive properties, especially when the edema is so close to the fovea.
Jump down to form below to submit your own comments